Plus Therapeutics CEO presents at JonesResearch webcast; no material new details in filing

PLUS THERAPEUTICS, INC.

CEO Marc Hedrick presented at a JonesResearch webcast on March 12, 2024.
Presentation slides filed as Exhibit 99.1 but no specific financial or operational data extracted from filing text.
Slides to be used in upcoming investor meetings as part of Regulation FD disclosure.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.